# Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus

> **NCT04908280** · PHASE2 · COMPLETED · sponsor: **University of Rochester** · enrollment: 10 (actual)

## Conditions studied

- Discoid Lupus Erythematosus

## Interventions

- **DRUG:** Ruxolitinib

## Key facts

- **NCT ID:** NCT04908280
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-04
- **Primary completion:** 2024-03-04
- **Final completion:** 2024-03-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04908280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04908280, "Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04908280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*